Seeding and propagation of untransformed mouse mammary cells in the lung

The acquisition of metastatic ability by tumor cells is considered a late event in the evolution of malignant tumors. We report that untransformed mouse mammary cells that have been engineered to express the inducible oncogenic transgenes MYC and Kras(D12), or polyoma middle T, and introduced into the systemic circulation of a mouse can bypass transformation at the primary site and develop into metastatic pulmonary lesions upon immediate or delayed oncogene induction. Therefore, previously untransformed mammary cells may establish residence in the lung once they have entered the bloodstream and may assume malignant growth upon oncogene activation. Mammary cells lacking oncogenic transgenes displayed a similar capacity for long-term residence in the lungs but did not form ectopic tumors.     

Renovating dependency and self-reliance for participatory sustainable development

Dependency stands for manygrievances and is generally considered asymptom of oppression. An opposing concept,offered as the preferred state, isself-reliance. Dependency and self-reliance arekey concepts in sustainable developmentprograms that feature participatory approaches.Some of the ways in which development projectsemploy the concepts of dependency andself-reliance, however, are troubling.Dependency and self-reliance in two programsfor participatory sustainable development areexamined, one in Canada and the other in NewZealand. Frameworks for dependency and self-reliance aredrawn from social psychology and philosophy toexamine problematic aspects associated with theconcepts. Analysis produced a proposal foruse of the term situatedinterdependence as a way to cast the outcomesof participatory sustainable development moreprecisely. The location of the cases (Canadaand New Zealand) centers the discussion withina context of industrialized agriculture, butalso points to issues pertinent to developingcountries.     

Use of pimobendan in 170 cats (2006–2010)

Hypothesis/ObjectivesTo describe the therapeutic use of pimobendan in cats, describe the patient population to which it was administered, document potential side effects and report the clinical course following administration of pimobendan in conjunction with standard heart failure therapy. It is hypothesized that cats with advanced heart disease including congestive heart failure from a variety of causes will tolerate pimobendan with a minimum of side effects when used in treatment in conjunction with a variety of other medications.Animals, materials and methodsOne hundred and seventy client owned cats with naturally occurring heart disease, one hundred and sixty four of which had congestive heart failure. Medical records were reviewed and owners and referring veterinarians were contacted for follow-up data. Data collected included pimobendan dose, other medications administered concurrently, data collected at physical examination, presence or absence of heart failure, adverse effects, classification of heart disease, echocardiographic data and survival time. The data were analyzed for significance between the initial visit and any follow-up visits.ResultsAll cats were treated with pimobendan. The median pimobendan dose was 0.24 mg/kg q 12 h. Pimobendan was used in combination with multiple concurrent medications including angiotensin converting enzyme inhibitors, diuretics and anti-thrombotics. Five cats (3.0%) had potential side effects associated with pimobendan. One cat (0.6%) had presumed side effects severe enough to discontinue pimobendan use. Median survival time for 164 cats with congestive heart failure after initiation of pimobendan was 151 days (range 1–870).ConclusionPimobendan appears to be well tolerated in cats with advanced heart disease when used with a variety of concurrent medications. Randomized controlled studies need to be performed to accurately assess whether it is efficacious for treatment of congestive heart failure in cats.     

Spatial variation of soil enzyme activities and microbial functional diversity in temperate alley cropping systems

Spatially dependent patterns in microbial properties may exist in temperate alley cropping systems due to differences in litter quality and microclimate in areas under trees compared to those in the alleys. The effect of tree row location was evaluated for its impact on soil enzyme activities and Biolog substrate use patterns. Soils were sampled to a depth of 30 cm at the tree row and at the middle of the alley at two sites: a 21-year-old pecan (Carya illinoinensis)/bluegrass (Poa trivials) intercrop (Pecan site) and a 12-year-old silver maple (Acer saccharinum)/soybean (Glycine max)–maize (Zea mays) rotation (Maple site). Sampling was done in fall 2001 and summer 2002. β-Glucosidase activities, Biolog patterns expressed as average well color (AWC), substrate richness, and Shannon diversity index, and total Kjeldahl nitrogen (TKN) were significantly higher (P<0.05) in the tree row than at the middle of the alley for surface soils at the Pecan site. Fluorescein diacetate (FDA) hydrolytic activity was also higher at the tree row for soils sampled in the fall, but did not differ significantly for soils sampled in the summer. At the Maple site, AWC and substrate richness were significantly higher at the tree row for soils sampled in 2001. Soil volumetric water content and temperature were generally lower in the tree row at the Maple site. The results of this study suggest that functionally different microbial populations may be present under pecan trees compared to cropped alleys which may promote disparities in nutrient availability necessitating differential long-term nutrient management in such alley cropping systems.